NCT03480984View on ClinicalTrials.gov

Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

January 5, 2020

Study Completion Date

January 31, 2020

Conditions
Thoracic Diseases
Interventions
OTHER

Programmed Intermittent Bolus

6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus

OTHER

Continuous Infusion

6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER